Abbreviations: NSCLC ϭ non-small cell lung cancer; ppo ϭ predicted postoperative; V o 2 max ϭ maximal oxygen uptake during exercise; Wmax ϭ workload at maximum exercise L ung cancer is currently the most common cause of cancer mortality throughout the world. It is the second most frequent type of cancer among men and women. 1,2 Non-small cell lung cancer (NSCLC) accounts for 80% of all newly diagnosed lung cancers. At present, complete resection offers the best prospects and results in cure in a substantial number of patients with NSCLC. In order to determine whether lung resection is feasible in patients with NSCLC and to what extent, resectable patients need to be carefully screened for their cardiopulmonary reserve. The best and most frequently used indicators for postoperative lung function are the FEV 1 predicted postoperative (ppo), 3-6 diffusion capacity of the lung for carbon monoxide ppo, 6 -9 and maximal oxygen uptake (V o 2 max) during exercise ppo. 4, 10, 11 There is consensus in the literature that lobectomy leads to very little permanent functional deficit after 6 months. 4 Pneumonectomy causes a more permanent deficit that is higher for pulmonary function (ie,
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ung cancer is currently the most common cause of cancer mortality throughout the world. It is the second most frequent type of cancer among men and women. 1, 2 Non-small cell lung cancer (NSCLC) accounts for 80% of all newly diagnosed lung cancers. At present, complete resection offers the best prospects and results in cure in a substantial number of patients with NSCLC. In order to determine whether lung resection is feasible in patients with NSCLC and to what extent, resectable patients need to be carefully screened for their cardiopulmonary reserve. The best and most frequently used indicators for postoperative lung function are the FEV 1 predicted postoperative (ppo), 3-6 diffusion capacity of the lung for carbon monoxide ppo, 6 -9 and maximal oxygen uptake (V o 2 max) during exercise ppo. 4, 10, 11 There is consensus in the literature that lobectomy leads to very little permanent functional deficit after 6 months. 4 Pneumonectomy causes a more permanent deficit that is higher for pulmonary function (ie, FVC and FEV 1 ) than for exercise capacity (V o 2 max). 4 FVC and FEV 1 are lowered by approximately 33%, whereas V o 2 max is decreased by approximately 20%. However, little is known about long-term (Ͼ 1 year postoperative) effects of pneumonectomy on lung function and exercise tolerance.
Several formulas are in use aiming to predict postoperative lung function after resection. [12] [13] [14] In general, these formulas can be divided into two categories. The first category of formulas calculates postoperative FVC and FEV 1 by the number of segments to be resected. 13 The second category of formulas includes the function of these segments by measuring their actual perfusion preoperatively. 12, 14, 15 These formulas proved reasonably valid when the predicted lung function was compared with the one measured relatively soon, within 3 months, after the operation. Since recruitment of underperfused or overventilated lung segments may occur after lung resection, especially after pneumonectomy, 16, 17 it is still unclear what the validity of these formulas might be for predicting lung function at a much later stage. Furthermore, these formulas were validated in a small number of patients after pneumonectomy. Nevertheless, they are worldwide accepted in guidelines. 3,4,18 Therefore, our main study objective was to investigate the validity of these formulas in pneumonectomy patients surviving for Ͼ 2 years after the operation. Subsequently, we studied trends in postoperative lung function and examined the implications of pneumonectomy on exercise capacity in patients surviving for Ͼ 1 year after the operation.
Materials and Methods
In a retrospective study, all data of patients who underwent pneumonectomy in a nonuniversity teaching hospital between 1993 and 1998 and survived for Ͼ 1 year after the operation were evaluated. Informed consent was obtained.
From the patient records, the following characteristics were gathered: demographic data, tumor histology and stage, date of surgery, site of operation, and presence of COPD, according to American Thoracic Society criteria. 19 We used these data to answer our three research questions.
ppo Lung Function FEV 1 -ppo and FVC-ppo were calculated by using the two most commonly used formulas [12] [13] [14] : 
where S is the number of resected lung segments, and each segment accounts for 1/19 of total lung function. The predicted and observed postoperative lung function data measured in the third year after the pneumonectomy were compared. We used the last available data in that third postoperative year for analysis.
Trends in Postoperative Lung Function
If more than two postoperative lung function tests were available, the changes in postoperative lung function over time were analyzed. These lung function tests had to be done at least Ͼ 6 months postoperatively and with a minimum interval of 12 months between the first and last available test.
Exercise Capacity
The preoperative and postoperative maximal incremental exercise test results, performed according to European Respiratory Society criteria, 20 were compared. The postoperative test had to be done Ͼ 1 year after the operation. Ventilatory limitation of exercise capacity was defined as follows 21 : (1) Pco 2 at maximum exercise being Ͼ 45 mm Hg or, (2) ventilation at maximum exercise Ն 37.5 ϫ FEV 1 .
Statistics
Statistical software (SPSS 9.0; SPSS; Chicago, IL) was used for statistical analysis. For the evaluation of the two formulas for predicting postoperative lung function, scatterplots were made and regression analysis performed with the ppo lung function as the independent variable and the observed postoperative lung function as the dependent variable. Long-term trends in lung function after pneumonectomy were studied by linear regression analysis. 22, 23 Results
Patients
From 1993 until 1998, 76 patients underwent pneumonectomy in our hospital. Forty-four patients were excluded from the study, 17 patients because of missing data, 26 patients died within 1 year after the operation, and 1 patient refused to participate. Table  1 presents initial patient characteristics of the 32 included patients compared to the dropouts and the total patient group. There were no statistical significant differences between the groups. Figure 1 shows a schematic overview of evaluable postoperative data and dropouts for each separate research question.
The diagnosis of lung malignancy was confirmed histologically in 31 patients; 1 patient underwent pneumonectomy because of an abscess with persisting empyema. Of all 31 malignant tumors, 20 were squamous cell carcinoma, 7 were adenocarcinoma, 2 were large cell undifferentiated carcinoma, 1 was adenocystic carcinoma, and 1 was a carcinoid tumor. Adjuvant radiotherapy was administered to 10 patients, 9 patients because of residual disease and 1 patient because of adenoid cystic carcinoma of the left main bronchus; 3 patients were treated with adjuvant chemotherapy.
Predicting Postoperative Lung Function
Scatterplots of predicted lung function data according to both formulas vs observed postoperative lung function data obtained in the third year after pneumonectomy are depicted in Figures 2, 3 , as well as the results of the linear regression analysis. These figures show that in patients surviving for Ͼ 2 years after pneumonectomy, calculation of ppo FVC and FEV 1 by both formulas correlates well with the observed postoperative FVC and FEV 1 . Linear regression analysis showed that the coefficient of determination (R 2 ) was higher for the Kristersson/ Olsen formula than the Juhl and Frost formula. This indicates that the formula by Kristersson et al 12 and Olsen et al 14 was more accurate in predicting postoperative FVC and FEV 1 than the formula by Juhl and Frost 13 for the investigated postoperative year. Furthermore, the formula by Juhl and Frost 13 predicted postoperative FEV 1 roughly 300 mL lower than the Kristersson/Olsen formula.
Trends in Postoperative Lung Function
Long-term postoperative changes in lung function of individual patients could be analyzed in 26 patients. The number of postoperative lung function tests varied between 3 tests and 12 tests (mean, 7 tests), and the mean time interval between the operation and most recent lung function test over which trends were analyzed was 9.9 Ϯ 63.0 months (Ϯ SD). The mean annual decline in FEV 1 was 44 mL. Of 26 patients, 6 patients had improvement in FEV 1 postoperatively, 10 patients had a decline of 0 to 50 mL/yr in FEV 1 , 7 patients had a decline of 50 to 100 mL/yr in FEV 1 , and 3 patients had a decline Ͼ 100 mL/yr in FEV 1 . Table 2 shows the results of the preoperative and postoperative exercise tests. These were available in 17 of 32 patients, with a mean time interval between the operation and the postoperative exercise test of 38 Ϯ 21.4 months (range, 12 to 77 months). Decreases in workload at maximum exercise (Wmax) and V o 2 max were 27% and 30%, respectively. Preoperatively, maximal exercise tolerance was restricted due to a limited ventilatory capacity in 4 of these 17 patients, whereas postoperatively this was the case in 5 of these 17 patients. In all cases, it was concluded that maximal exercise was restricted due to a limited ventilatory capacity because Pco 2 exceeded the 45 mm Hg limit at maximum exercise.
Exercise Capacity

Comments
This study shows that calculation of FVC-ppo and 24 found this underestimation of FEV 1 -ppo to be approximately 500 mL at 7.2 months (mean) [range, 24 days to 5 years] after pneumonectomy. In our study, we found an underestimation of FEV 1 -ppo of 225 mL, indicating further decrease in FEV 1 in this period of time or a better prediction of FEV 1 -ppo by the Juhl and Frost formula a few years after pneumonectomy. Bolliger et al 25 recently found that both predictions of postoperative cardiopulmonary function by perfusion scan and quantitative CT scan (6 months postoperatively) were useful irrespective of the extent of resection. Unfortunately, we did not choose the use of quantitative CT scan for long-term prediction in our study, which would be very interesting to do.
In healthy nonsmokers, FEV 1 physiologically decreases with approximately 30 mL/yr. In current, male, heavy cigarette smokers (Ͼ 25 cigarettes per day), this decline is approximately 60 mL/yr. 26, 27 The mean annual decline in FEV 1 was 44 mL in our study. No clear correlation between the amount of decline and presence of COPD, adjuvant radiotherapy, or adjuvant chemotherapy could be detected. When looking at the patients individually, we found that 6 of 26 patients showed an improvement in their FEV 1 in time after their pneumonectomy, whereas 3 patients showed a rapid deterioration of Ͼ 100 mL/ yr. One of the possible explanations for these findings might be the past and current smoking status of the patients. Unfortunately, we were not able to determine the exact past and current smoking status in our patients because of the retrospective nature of our study. A possible explanation for the improvement in FEV 1 we observed in six of our patients might be a better treatment of an underlying obstructive pulmonary disease or the occurrence of recruitment and distention of alveoli and capillaries after a pneumonectomy. Some investigators 16, 17 have suggested that this might be the main adaptive mechanism of the lung to the new situation after pneumonectomy. Laros 28 found that because of recruitment and alveolar distention, the vital capacity increased slightly during the first few years after pneumonectomy. In our study, Wmax and V o 2 max decreased 27% and 30%, respectively, at approximately 38 months after the operation. Probably this decrease is an underestimation of the real decrease because nine patients postoperatively could not be tested due to death or shortness of breath. Our data compare well with those of Nugent et al, 29 who found that pneumonectomy was associated with impaired exercise performance and reduced V o 2 max by 28% 6 months after the operation. Others found reductions of 16% 30 and 20% 4,31 at 6 months after the operation. These results suggest that long-term exercise performance might already be predicted at 6 months postoperatively.
Only 17 of the 32 patients were able to perform a postoperative exercise test, of which 5 patients were found to be ventilatory limited to exercise. When taking into account the 15 patients who were not available for postoperative exercise testing, we believe the actual number of ventilatory limited patients might be higher. Of these 15 patients, 5 patients were not able to perform this test because of poor lung function and shortness of breath, indicating that exercise limitation might be due to ventilatory problems. Six patients, including four patients who underwent preoperative ventilatory limited exercise tests, died before having performed a postoperative exercise test. Death was attributed to respiratory failure in four of these six patients also, indicating ventilatory limitation postoperatively. Adding these 9 patients without a postoperative exercise test to the 5 patients with a postoperative exercise test results in 14 of 32 patients (44%) probably being ventilatory limited to exercise after pneumonectomy. Two of these nine patients also experienced cardiac comorbidity, besides their pulmonary limitations, which probably contributed to their limited exercise capacity. The preoperative FVC and FEV 1 of the nine patients who were not able to perform an exercise test postoperatively were compared to the preoperative FVC and FEV 1 of the patients in whom it was proven that ventilatory problems were the reason for postoperative exercise limitation. The preoperative lung function results in these nine patients were worse, which makes it very likely that these nine patients also had ventilatory limitation as a reason for a restricted exercise capacity.
When considering our results, it might be argued that our results are biased because of missing data. Because we found no indications for selective drop out when comparing the final study group and the dropout group on their initial patient characteristics, we have no indication that this might be the case. This study was conducted solely to answer our three research questions in long-term survivors. Also, compared to previous studies, 6, 24 we were able to include a relatively large number of patients, which make our results more robust. Nevertheless, because of the retrospective character of this study, our results need to be confirmed by a prospective study.
In conclusion, this study showed that the Kristersson/Olsen formula was a better predictor of postoperative FVC and FEV 1 than the Juhl and Frost formula in patients surviving for Ͼ 2 years after pneumonectomy. Secondly, the annual decline in FEV 1 in these patients is almost the same as in healthy patients without COPD. Finally, we found that Wmax Ͼ 1 year after pneumonectomy (mean interval of 38 months) decreased by 27% and V o 2 max decreased by 30%, at least. Knowledge of these changes in lung function and exercise tolerance in these patients is extremely useful for the preoperative assessment and counseling of patients who are eligible for pneumonectomy. 
